Apollon Wealth Management LLC Invests $240,000 in Tempus AI, Inc. $TEM

Apollon Wealth Management LLC purchased a new stake in Tempus AI, Inc. (NASDAQ:TEMFree Report) in the second quarter, according to its most recent filing with the SEC. The fund purchased 3,770 shares of the company’s stock, valued at approximately $240,000.

Several other large investors have also recently added to or reduced their stakes in the company. ARK Investment Management LLC boosted its holdings in Tempus AI by 35.9% in the first quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company’s stock worth $361,867,000 after purchasing an additional 1,981,755 shares during the period. Vanguard Group Inc. raised its holdings in shares of Tempus AI by 6,247.5% during the first quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company’s stock worth $289,204,000 after purchasing an additional 5,900,668 shares during the period. Nikko Asset Management Americas Inc. lifted its position in shares of Tempus AI by 31.5% in the 1st quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company’s stock worth $205,401,000 after buying an additional 1,021,460 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. lifted its position in shares of Tempus AI by 31.4% in the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company’s stock worth $205,284,000 after buying an additional 1,016,384 shares during the last quarter. Finally, CloudAlpha Capital Management Limited Hong Kong acquired a new position in shares of Tempus AI in the 1st quarter valued at about $34,119,000. 24.22% of the stock is currently owned by institutional investors.

Insider Activity

In other Tempus AI news, Director Theodore Leonsis sold 44,000 shares of the business’s stock in a transaction dated Wednesday, August 13th. The shares were sold at an average price of $69.90, for a total transaction of $3,075,600.00. Following the sale, the director directly owned 86,756 shares in the company, valued at approximately $6,064,244.40. The trade was a 33.65% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO James William Rogers sold 7,528 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total transaction of $561,965.20. Following the completion of the sale, the chief financial officer directly owned 138,473 shares of the company’s stock, valued at approximately $10,337,009.45. This represents a 5.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 933,662 shares of company stock worth $68,070,993 in the last 90 days. 26.27% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on TEM. Morgan Stanley increased their price objective on shares of Tempus AI from $65.00 to $68.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 12th. Piper Sandler reaffirmed a “neutral” rating on shares of Tempus AI in a report on Friday, August 8th. Bank of America increased their price target on Tempus AI from $68.00 to $70.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 25th. BTIG Research raised their price target on Tempus AI from $75.00 to $85.00 and gave the stock a “buy” rating in a report on Wednesday, August 20th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Tempus AI in a research report on Wednesday, October 8th. Seven analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Tempus AI currently has a consensus rating of “Hold” and an average price target of $71.83.

Get Our Latest Report on Tempus AI

Tempus AI Price Performance

NASDAQ TEM opened at $87.78 on Friday. The company has a 50-day moving average price of $82.18 and a two-hundred day moving average price of $66.23. Tempus AI, Inc. has a 52 week low of $31.36 and a 52 week high of $104.32. The stock has a market cap of $15.25 billion, a price-to-earnings ratio of -73.76 and a beta of 4.87. The company has a current ratio of 1.54, a quick ratio of 1.43 and a debt-to-equity ratio of 2.58.

Tempus AI (NASDAQ:TEMGet Free Report) last issued its quarterly earnings data on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.23) by $0.01. The business had revenue of $314.64 million during the quarter, compared to the consensus estimate of $296.84 million. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The business’s revenue was up 89.5% on a year-over-year basis. During the same period in the previous year, the firm posted ($6.86) earnings per share. Tempus AI has set its FY 2025 guidance at EPS. Analysts forecast that Tempus AI, Inc. will post -6.15 EPS for the current year.

Tempus AI Profile

(Free Report)

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Recommended Stories

Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEMFree Report).

Institutional Ownership by Quarter for Tempus AI (NASDAQ:TEM)

Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.